HomeNewsTrendsSportsCoronavirus impact: Premier League clubs discuss options but left with no alternatives
Trending Topics

Coronavirus impact: Premier League clubs discuss options but left with no alternatives

Representatives of the 20 teams took part in a conference call to look at various possible options for restarting the season and remain committed to completing the fixtures rather than voiding the season.

April 17, 2020 / 20:05 IST
Story continues below Advertisement

Premier League clubs on April 17 discussed possible models for finishing the current season but did not consider a specific date for play to resume while U.K. government lockdown restrictions remain in place.

Representatives of the 20 teams took part in a conference call to look at various possible options for restarting the season and remain committed to completing the fixtures rather than voiding the season.

Story continues below Advertisement

Also read: Coronavirus pandemic | UEFA aims for July restart for leagues, wants them completed

But after the government announced on April 16 that the lockdown would remain in place for at least another three weeks, all options remain hypothetical.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show